Trump’s Withdrawal from WHO and Paris Agreement Threatens Africa’s Health Infrastructure

The Trump administration’s decision to withdraw from both the World Health Organization (WHO) and the Paris Agreement carries severe consequences for Africa’s health infrastructure. This move jeopardizes decades of progress in combating diseases such as HIV, malaria, and tuberculosis, which remain some of the continent’s primary public health challenges.

The Impact on Disease Control Efforts

Recently, pharmaceutical companies like Takeda and Bayer have shown renewed interest in tropical disease research and development, focusing on innovative ways to combat diseases such as dengue and river blindness. These efforts are crucial. However, African countries prioritize maintaining the current gains in controlling a broader array of diseases, including tuberculosis, HIV, malaria, Zika, and Ebola.

Strengthening the resilience of healthcare systems that are often underfunded and vulnerable is paramount, especially in the context of accelerating climate change. The expected rise in temperature and unpredictable weather patterns could exacerbate existing public health issues.

Compounding Risks from Climate Change

Global warming is likely to reshape the epidemiological landscape, potentially leading to mass displacements across the Global South and facilitating the spread of diseases like malaria, cholera, and Chagas. Ecological disruptions might also enhance mosquito populations and other disease vectors.

Investment in robust disease surveillance and pre-emptive measures are essential to meet these emerging challenges head-on. However, the U.S. exit from the WHO undermines global health information networks critical to controlling infectious disease outbreaks and developing vital vaccines.

The Role of WHO and its Partnerships in Africa

Since its founding in 1948, the WHO has been a cornerstone of international health cooperation. In Africa, the organization works closely with the African Union’s Centre for Disease Control (AU-CDC), established in 2016 following the Ebola crisis in West Africa.

The AU-CDC has forged partnerships with entities such as the West African Health Organization (WAHO) and the African Union’s New Partnership for Africa’s Development (AU-NEPAD) to advance disease surveillance, prevention, diagnosis, and treatment. This collaboration has bolstered the continent’s ability to respond to new threats like Lassa fever and cholera.

Investment Gaps and the Need for Solutions

The urgency of these challenges was highlighted during COP29 in Baku, where delegates emphasized the need for more investment in healthcare projects within low- and middle-income nations. They stressed the importance of local vaccine and antibiotic production to combat antimicrobial resistance and improve food security.

However, the absence of U.S. support for climate-health initiatives under the Paris Agreement presents a significant hurdle. The Trump administration’s former President’s Emergency Plan for Adaptation and Resilience (PREPARE) committed $3 billion annually to climate adaptation. Without this funding, many vulnerable countries rely heavily on the International Development Association (IDA) for low-interest development credits and grants.

Relying solely on IDA risks hindering efforts to establish climate-resilient healthcare systems and modernize infrastructure.

A Global Call to Action

The future of public health in Africa lies in global cooperation, robust investment, and innovative solutions. Countries must pool resources to ensure that healthcare systems remain strong and adaptable to climate-driven changes in disease patterns.

Investments in research, development, and infrastructure can safeguard progress made in disease control and prepare regions for enhanced resilience.

If you’re interested in writing for International Policy Digest, please send us an email via submissions@intpolicydigest.org